Observational Study to Assess Intravitreal Aflibercept Injections Used in a "Treat and Extend" Regimen in Treatment-naïve Wet Age-related Macular Degeneration Patients
Conditions
- Wet Age-related Macular Degeneration
Interventions
- DRUG: Aflibercept (Eylea, BAY86-5321)
Sponsor
Bayer
Collaborators